Delegated Regulation to the Falsified Medicines Directive (FMD) 2011/62/EU, published on the 9 February 2016, will come in to force by February 2019. The new regulation will require manufacturers to place safety features on all medicines and contribute financially to the establishment of an IT verification system that will allow the assessment of the authenticity of a medicine at the time of supply to the patient.
ATL is one of the approved system supplier in the UK. Time is ticking until 9 Feb 2019, the pressure is on! Contact us to give you a free demo.